- Home
- AZN vs GS Comparison
AZN vs GS Comparison
Compare AZN & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- GS
- Stock Information
- Founded
- AZN 1992
- GS 1869
- Country
- AZN United Kingdom
- GS United States
- Employees
- AZN N/A
- GS N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- GS Investment Bankers/Brokers/Service
- Sector
- AZN Health Care
- GS Finance
- Exchange
- AZN Nasdaq
- GS Nasdaq
- Market Cap
- AZN 225.1B
- GS 182.7B
- IPO Year
- AZN 1993
- GS 1999
- Fundamental
- Price
- AZN $64.87
- GS $489.67
- Analyst Decision
- AZN Strong Buy
- GS Buy
- Analyst Count
- AZN 7
- GS 16
- Target Price
- AZN $89.75
- GS $593.43
- AVG Volume (30 Days)
- AZN 6.5M
- GS 3.5M
- Earning Date
- AZN 04-29-2025
- GS 04-14-2025
- Dividend Yield
- AZN 2.37%
- GS 2.45%
- EPS Growth
- AZN 18.11
- GS 77.31
- EPS
- AZN 4.50
- GS 40.54
- Revenue
- AZN $54,073,000,000.00
- GS $52,164,000,000.00
- Revenue This Year
- AZN $8.64
- GS $12.04
- Revenue Next Year
- AZN $6.11
- GS $5.07
- P/E Ratio
- AZN $14.42
- GS $12.08
- Revenue Growth
- AZN 18.04
- GS 15.34
- 52 Week Low
- AZN $61.24
- GS $387.12
- 52 Week High
- AZN $87.68
- GS $672.19
- Technical
- Relative Strength Index (RSI)
- AZN 29.48
- GS 38.43
- Support Level
- AZN $61.24
- GS $447.11
- Resistance Level
- AZN $75.70
- GS $522.00
- Average True Range (ATR)
- AZN 2.12
- GS 27.61
- MACD
- AZN -1.05
- GS -4.64
- Stochastic Oscillator
- AZN 25.10
- GS 32.81
Stock Price Comparison Chart: AZN vs GS
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.